NCT00279955

Brief Summary

The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart failure related adverse events and health care utilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,024

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2004

Longer than P75 for all trials

Geographic Reach
1 country

93 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2004

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 18, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 20, 2006

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

December 8, 2011

Completed
Last Updated

June 15, 2012

Status Verified

June 1, 2012

Enrollment Period

3.8 years

First QC Date

January 18, 2006

Results QC Date

July 20, 2011

Last Update Submit

June 11, 2012

Conditions

Keywords

Heart Failure, CongestiveImplantable Cardioverter-Defibrillators

Outcome Measures

Primary Outcomes (1)

  • Occurrence of Heart Failure (HF) Related Adverse Event (AE)

    Number of participates with HF realted adverse event will be reported. Time to the first HF related Adverse event in the "Follow-up Period" from the 6-month visit to the 12-month visit is compared between two risk groups. The goal was to test if there is a significant difference in time to first HF-related adverse event between two groups. A heart failure related (HF-related) adverse event is defined as an adverse event that results in a subject's worsening HF or related to the heart's inability to meet the metabolic demands of the body.

    From 6 month to the 12 month visit

Secondary Outcomes (2)

  • Occurrence of Heart Failure (HF) Related Healthcare Utilization (HU)

    6 month to the 12 month visit

  • Occurrence of Heart Failure (HF) Related Pulmonary Congestion Event (PCE)

    6 month to the 12 month visit

Interventions

Patients with an ICD indication, a CRT indication and symptomatic heart failure who are implanted with a Cardiac Resynchronization Therapy Device.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients receiving a specified Medtronic Implantable Cardiac Resynchronization Therapy Defibrillator device where informed consent and/or authorization to use and disclose health information permission has been granted.

You may qualify if:

  • Patients who meet the ICD indications
  • Patients with Class III or IV heart failure.
  • Patients receiving or who received a Medtronic CRT ICD within the previous 3 months.
  • Patient must sign and date informed consent, and be 18 years of age or greater.
  • Patient must be available for follow up visits, and be willing and able to comply with study protocol.

You may not qualify if:

  • Patient with acute myocardial infarction (MI), coronary artery bypass graft surgery (CABG) or percutaneous coronary angioplasty (PTCA)/stent within the last month.
  • Patient with a mechanical right heart valve.
  • Patient with chronic (permanent) atrial arrhythmias.
  • Patient with life expectancy of less than 12 months.
  • Patient with status post heart transplant
  • Patient undergoing kidney dialysis
  • Patients enrolled in a concurrent study that may confound the results of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (93)

Unknown Facility

Huntsville, Alabama, United States

Location

Unknown Facility

Phoenix, Arizona, United States

Location

Unknown Facility

Scottsdale, Arizona, United States

Location

Unknown Facility

Little Rock, Arkansas, United States

Location

Unknown Facility

Loma Linda, California, United States

Location

Unknown Facility

San Diego, California, United States

Location

Unknown Facility

Denver, Colorado, United States

Location

Unknown Facility

Guilford, Connecticut, United States

Location

Unknown Facility

Bradenton, Florida, United States

Location

Unknown Facility

Fort Lauderdale, Florida, United States

Location

Unknown Facility

Key Largo, Florida, United States

Location

Unknown Facility

Melbourne, Florida, United States

Location

Unknown Facility

Miami, Florida, United States

Location

Unknown Facility

Orlando, Florida, United States

Location

Unknown Facility

Palm Beach Gardens, Florida, United States

Location

Unknown Facility

Pensacola, Florida, United States

Location

Unknown Facility

Safety Harbor, Florida, United States

Location

Unknown Facility

Tallahassee, Florida, United States

Location

Unknown Facility

Tampa, Florida, United States

Location

Unknown Facility

Winter Park, Florida, United States

Location

Unknown Facility

Atlanta, Georgia, United States

Location

Unknown Facility

Augusta, Georgia, United States

Location

Unknown Facility

Honolulu, Hawaii, United States

Location

Unknown Facility

Evanston, Illinois, United States

Location

Unknown Facility

Maywood, Illinois, United States

Location

Unknown Facility

Merrionette Park, Illinois, United States

Location

Unknown Facility

Rockford, Illinois, United States

Location

Unknown Facility

Springfield, Illinois, United States

Location

Unknown Facility

Winfield, Illinois, United States

Location

Unknown Facility

Topeka, Kansas, United States

Location

Unknown Facility

Wichita, Kansas, United States

Location

Unknown Facility

Edgewood, Kentucky, United States

Location

Unknown Facility

Florence, Kentucky, United States

Location

Unknown Facility

Louisville, Kentucky, United States

Location

Unknown Facility

Covington, Louisiana, United States

Location

Unknown Facility

Monroe, Louisiana, United States

Location

Unknown Facility

Portland, Maine, United States

Location

Unknown Facility

Salisbury, Maryland, United States

Location

Unknown Facility

Takoma Park, Maryland, United States

Location

Unknown Facility

Grand Rapids, Michigan, United States

Location

Unknown Facility

Marquette, Michigan, United States

Location

Unknown Facility

Petoskey, Michigan, United States

Location

Unknown Facility

Traverse City, Michigan, United States

Location

Unknown Facility

Minneapolis, Minnesota, United States

Location

Unknown Facility

Saint Cloud, Minnesota, United States

Location

Unknown Facility

St Louis, Missouri, United States

Location

Unknown Facility

Missoula, Montana, United States

Location

Unknown Facility

Las Vegas, Nevada, United States

Location

Unknown Facility

Manchester, New Hampshire, United States

Location

Unknown Facility

Cherryhill, New Jersey, United States

Location

Unknown Facility

Ridgewood, New Jersey, United States

Location

Unknown Facility

Sewell, New Jersey, United States

Location

Unknown Facility

New York, New York, United States

Location

Unknown Facility

The Bronx, New York, United States

Location

Unknown Facility

West Islip, New York, United States

Location

Unknown Facility

Williamsville, New York, United States

Location

Unknown Facility

Charlotte, North Carolina, United States

Location

Unknown Facility

Durham, North Carolina, United States

Location

Unknown Facility

Greensboro, North Carolina, United States

Location

Unknown Facility

Raleigh, North Carolina, United States

Location

Unknown Facility

Bismarck, North Dakota, United States

Location

Unknown Facility

Fargo, North Dakota, United States

Location

Unknown Facility

Cincinnati, Ohio, United States

Location

Unknown Facility

Columbus, Ohio, United States

Location

Unknown Facility

Dayton, Ohio, United States

Location

Unknown Facility

Elyria, Ohio, United States

Location

Unknown Facility

Lakewood, Ohio, United States

Location

Unknown Facility

Mayfield Heights, Ohio, United States

Location

Unknown Facility

Westlake, Ohio, United States

Location

Unknown Facility

Medford, Oregon, United States

Location

Unknown Facility

Camp Hill, Pennsylvania, United States

Location

Unknown Facility

Erie, Pennsylvania, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, United States

Location

Unknown Facility

Pittsburgh, Pennsylvania, United States

Location

Unknown Facility

Wormleysburg, Pennsylvania, United States

Location

Unknown Facility

York, Pennsylvania, United States

Location

Unknown Facility

Pawtucket, Rhode Island, United States

Location

Unknown Facility

Providence, Rhode Island, United States

Location

Unknown Facility

Columbia, South Carolina, United States

Location

Unknown Facility

Spartanburg, South Carolina, United States

Location

Unknown Facility

Sioux Falls, South Dakota, United States

Location

Unknown Facility

Knoxville, Tennessee, United States

Location

Unknown Facility

Nashville, Tennessee, United States

Location

Unknown Facility

Fairfax, Texas, United States

Location

Unknown Facility

Fort Worth, Texas, United States

Location

Unknown Facility

Lubbock, Texas, United States

Location

Unknown Facility

Burlington, Vermont, United States

Location

Unknown Facility

Lynchburg, Virginia, United States

Location

Unknown Facility

Norfolk, Virginia, United States

Location

Unknown Facility

Richmond, Virginia, United States

Location

Unknown Facility

Kirkland, Washington, United States

Location

Unknown Facility

Green Bay, Wisconsin, United States

Location

Unknown Facility

Madison, Wisconsin, United States

Location

Related Publications (2)

  • Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM; PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089.

  • Whellan DJ, O'Connor CM, Ousdigian KT, Lung TH; PARTNERS HF Study Investigators. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). Am Heart J. 2008 Nov;156(5):833-9, 839.e2. doi: 10.1016/j.ahj.2008.06.036. Epub 2008 Sep 23.

MeSH Terms

Conditions

Heart Failure

Interventions

Cardiac Resynchronization Therapy Devices

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Pacemaker, ArtificialElectrodesElectrical Equipment and SuppliesEquipment and Supplies

Results Point of Contact

Title
CRDM Core Clinical
Organization
Medtronic CRDM Clinical Research

Study Officials

  • David Whellan, MD

    Jefferson Heart Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2006

First Posted

January 20, 2006

Study Start

June 1, 2004

Primary Completion

March 1, 2008

Study Completion

June 1, 2008

Last Updated

June 15, 2012

Results First Posted

December 8, 2011

Record last verified: 2012-06

Locations